Researchers from the Max Delbrück Center and the DZHK are exploring how the effects of a mutated gene that causes severe hypertension but also protects the kidneys from being damaged can be used therapeutically

A mutation that causes severe hypertension also protects the kidneys from being damaged, reports a team led by Enno Klußmann of the Max Delbrück Center and the DZHK in “Kidney International”. The researchers are now exploring how the effects of the…

3 Min
More

Clinical trial run by Charité and the Max Delbrück Center has been awarded a grant of several million euros to test a new immunotherapy approach

While CAR-T cells have proven successful in treating certain types of leukemia and lymphoma, these immunotherapies can become even more effective. A clinical trial run by Charité and the Max Delbrück Center has been awarded a grant of several million…

2 Min
More

Max Delbrück Center has investigated how the sensory cells of the vagus nerve react to mechanical stimuli in the esophagus in the process of swallowing

Sensory cells in the vagus nerve can detect and locate food in the esophagus. Their signals help transport the food onward to the stomach. Signal failure leads to swallowing disorders, say a team led by Carmen Birchmeier at the Max Delbrück Center.…

2 Min
More

Winner of the Speed Lecture Award 2023 is Samantha Mendosa from Max Delbrück Center - BIMSB

Nine young scientists made it to the finals of the 17th edition of the Speed Lecture Award and presented their scientific projects to the audience in only three minutes at the BIONNALE on May 16 in Berlin.

1 Min
More

TimeTeller reads your inner clock: Tenth spin-off of the BIH Digital Health Accelerator pinpoints the best time to exercise, sleep and take medicine

An interdisciplinary team led by Prof. Angela Relógio, a scientist at Charité’s Molecular Cancer Research Center (MKFZ) and Institute for Theoretical Biology and the MSH Medical School Hamburg, has developed a non-invasive method for profiling a…

4 Min
More

Using an app to combat skin conditions: Nia Health receives millions in funding

The Berlin-based health tech start-up Nia Health receives 3.5 million euros in a seed financing round.

The company originates from the Charité Universitätsmedizin Berlin and operates leading dermatology apps, including “Nia,” the most widely…

1 Min
More

Eckert & Ziegler with Strong Sales Growth in the First Quarter of 2023

Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX) increased its sales by 16% to EUR 57.9 million in the first quarter of 2023. Net income amounted to EUR 4.7 million or EUR 0.23 per share and was thus 29% lower than in the…

2 Min
More

GeneQuine Biotherapeutics Changes Name to GQ Bio Therapeutics, Expands Facilities and Appoints Industry Veteran to Board

Hamburg, Germany, May 9, 2023 – GeneQuine Biotherapeutics GmbH today announced that it is changing its name to GQ Bio Therapeutics GmbH. Since 2012, the company has been working under the name GeneQuine Biotherapeutics

in the field of gene therapy…

2 Min
More

Evosep and Cellenion enter co-marketing agreement to boost single cell proteomics

Lyon, France, and Odense, Denmark; May 9, 2023: Today at AOHUPO in Singapore, Cellenion is pleased to announce a new co-marketing partnership with Evosep. This partnership will enable researchers to access a complete solution for single-cell…

2 Min
More

BIOTRONIK Receives CE Approval for the World’s First Pacemaker and CRT-P Family Approved for Left Bundle Branch Pacing

The Amvia family enables physiological pacing and workflow optimization to help physicians deliver exceptional patient-centric care with less effort.

 

2 Min
More
Show more items